A 2007 double-blind, multicenter trial (n=102) showed ALC 1,500 mg/day significantly improved tender point count, total myalgic score, depression, and musculoskeletal pain compared to placebo.[9] A 2015 RCT found ALC 1,500 mg/day comparable to duloxetine 60 mg/day for pain and depression.[8] Most notably, a 2023 RCT demonstrated that adding PEA 1,200 mg/day + ALC 2,000 mg/day to ongoing duloxetine + pregabalin therapy produced significantly greater improvements in Widespread Pain Index, FIQR, and FASmod scores.[7] Role in Treatment: ALC can be used as monotherapy or adjunctive therapy in fibromyalgia
L-Carnitine 500 mg from XXL Nutrition for daily use
Do not let more time pass while you feel less than your best as our team is here to help you today
To date, studies show that Moringa oleifera may lead to modest reductions in blood sugar and cholesterol
DAM in AD DAM is a unique subtype of microglia that emerges early during AD progression and is characterized by its localization near A plaques, along with phagocytic and lipid-metabolizing features (Figure 3, Table 1